Healthcare Investing and Market Perspectives by Michael Taylor
Michael Taylor is a former hedge fund manager and specialist in biotech equities, with more than 25 years of experience in trading and portfolio strategy. He is widely known in the FinTwit community for his candid macro views and insights on market cycles, risk-on/risk-off dynamics, and asset allocation. Taylor previously managed healthcare-focused portfolios at large asset management firms and now operates as an independent strategist and financial educator.
Since 2022, he has gained a large following on X (formerly Twitter) with over 165,000 followers. His posts frequently address Bitcoin, Ethereum, and crypto-linked equities like Coinbase and Riot Blockchain. Taylor analyzes digital assets through the lens of liquidity cycles, rate policy shifts, and momentum structures.
He does not run a crypto fund or participate in blockchain development but maintains a personal trading interest in digital assets. In 2023 and 2024, he disclosed short positions against speculative tokens and long trades in Bitcoin ETFs to express macroeconomic views. He has described Bitcoin as “a macro barometer, not a religion,” focusing on its correlation with global liquidity rather than ideology.
Taylor is a regular guest on financial podcasts and live discussions with other macro strategists. His voice is especially influential among retail investors who follow institutional strategies and use crypto as part of broader market rotation models.
High prices usually bring lower prices, Michael Taylor notes
High prices frequently result in future declines, as observed in markets such as INTC, according to Michael Taylor, co-founder and portfolio manager at Agora Trading. Taylor suggests that this ...
Michael Taylor: Crypto may eventually face major disruptions alongside advances in AI
Michael Taylor, co-founder and portfolio manager at Agora Trading, suggested that the cryptocurrency sector may be subject to significant challenges in the future, even as artificial intelligence ...
MRNA study may pose challenges for payers, Michael Taylor says
Michael Taylor, co-founder and portfolio manager at Agora Trading, expressed concern about the recent MRNA study and its results. He believes payers will face significant difficulties related to ...
Michael Taylor: Anthropic and OAI have over $800 billion in AI funding commitments contingent on IPOs or debt with double-digit yields
Anthropic and OAI have more than $800 billion in commitments to support further AI development, contingent on IPOs or debt offerings that could carry double-digit percent yields. The figure is ...
NVDA may resort to more drastic steps, Michael Taylor notes
Michael Taylor, co-founder and portfolio manager at Agora Trading, suggested that NVDA may take increasingly extreme measures, describing the company's practice of guaranteeing returns to its ...
Michael Taylor: Anthropic reduces IPO valuation from $2 trillion to $1.5 trillion
Anthropic has reduced its IPO valuation target from $2 trillion to $1.5 trillion. Michael Taylor, co-founder and portfolio manager at Agora Trading, questioned how Anthropic maintains a cost of ...
FJET IPO CEO founder exits and sells holdings, Michael Taylor notes
The CEO and founder of the FJET IPO by Lafferty & Co has left the company and is selling a 25% stake in the business. Michael Taylor, co-founder and portfolio manager at Agora Trading, added ...
Michael Taylor: PINK event held in partnership with Susan G. Komen in New York
A Party in Pink event took place in New York City in collaboration with Susan G. Komen. Michael Taylor, co-founder and portfolio manager at Agora Trading, acknowledged supporters and partners ...
ARKK is a major outperformer but share count falls each year, Michael Taylor notes
Michael Taylor, co-founder and portfolio manager at Agora Trading, observed that while ARKK has been a significant outperformer and has experienced fund flows, the ETF's share count has declined ...
Michael Taylor: TE faces funding challenges over Chinese ties
Michael Taylor, co-founder / portfolio manager at Agora Trading, observes that TE is seen as a Chinese solar company operating as an American firm, which he believes makes it difficult for the ...
FDA requires 1-year natural history group and P3 single arm study, Michael Taylor notes
Michael Taylor, co-founder / portfolio manager at Agora Trading, outlines his positive interpretation of recent FDA meeting minutes regarding BNTC. He highlights that the FDA has requested a ...
Michael Taylor: UTHR positioned for major new product story in 2027
Michael Taylor, co-founder and portfolio manager at Agora Trading, highlights that UTHR may have an important new product story emerging in 2027. He also humorously remarks about the possibility ...
Older investors may confront duration gaps, Michael Taylor notes
Michael Taylor, co-founder and portfolio manager at Agora Trading, remarks that many individuals in their 60s may have a mismatch in investment duration. The comment suggests concerns about the ...
Michael Taylor: Summit Therapeutics and AstraZeneca announce $2 billion preferred convertible deal in lung cancer
Michael Taylor, co-founder and portfolio manager at Agora Trading, highlights a new partnership between Summit Therapeutics and AstraZeneca for developing new standards of care in lung and other ...
AQRT to double TAM with Phase 2 Vitiligo study in $1 billion market, Michael Taylor notes
Michael Taylor, co-founder / portfolio manager at Agora Trading, highlights that AQRT has a planned Phase 2 go/nogo study for Vitiligo, an autoimmune pigmenting disorder, set for 4Q26. Taylor ...
Michael Taylor: Enterprise AI data center costs have quadrupled from 2 years ago
Michael Taylor, co-founder and portfolio manager at Agora Trading, flags a major concern related to artificial intelligence in enterprises. He points out that while enterprise AI initiatives are ...
FR and GB have highest debt and yields, Michael Taylor notes
Michael Taylor, co-founder and portfolio manager at Agora Trading, highlights that France and Great Britain currently have the highest debt levels and yields. He states that this situation ...
Michael Taylor: FJET identified as a little-known bear trade opportunity
Michael Taylor, co-founder and portfolio manager at Agora Trading, draws attention to FJET as one of his most comical bear trades. Taylor notes that the asset is not widely recognized and ...
Michael Taylor: Long-term yield curve makes U.S. homes less affordable
Michael Taylor, co-founder and portfolio manager at Agora Trading, discusses how shifts in the long end of the yield curve are impacting housing affordability in the U.S. Taylor suggests that ...
OAI and Anthropic require $1 trillion ROA by YE27, Michael Taylor argues
Michael Taylor, co-founder and portfolio manager at Agora Trading, questions the potential for artificial intelligence investments to deliver substantial returns. Taylor points out that OAI and ...
Michael Taylor: Fed could deliver many rate cuts in 2027
Michael Taylor, co-founder and portfolio manager at Agora Trading, predicts that the U.S. Federal Reserve could make multiple interest rate cuts in 2027. He also suggests that a single rate hike ...
